Senseonics Holdings (Senseonics Holdings) Debt-to-Equity : 1.34 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Debt-to-Equity?

Senseonics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.37 Mil. Senseonics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $47.41 Mil. Senseonics Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $35.80 Mil. Senseonics Holdings's debt to equity for the quarter that ended in Dec. 2023 was 1.33.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Senseonics Holdings's Debt-to-Equity or its related term are showing as below:

SENS' s Debt-to-Equity Range Over the Past 10 Years
Min: -29.26 Med: -0.39 Max: 3.37
Current: 1.34

During the past 10 years, the highest Debt-to-Equity Ratio of Senseonics Holdings was 3.37. The lowest was -29.26. And the median was -0.39.

SENS's Debt-to-Equity is ranked worse than
92.13% of 712 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SENS: 1.34

Senseonics Holdings Debt-to-Equity Historical Data

The historical data trend for Senseonics Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Debt-to-Equity Chart

Senseonics Holdings Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-13.71

-0.44

-0.34

-29.26

1.34

Senseonics Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															-29.26	0.63	0.88	0.91	1.34

Competitive Comparison of Senseonics Holdings's Debt-to-Equity

For the Medical Devices subindustry, Senseonics Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senseonics Holdings's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Debt-to-Equity falls into.

Senseonics Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Senseonics Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.368	+	47.409)	/	35.796
	=	1.33

Senseonics Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.368	+	47.409)	/	35.796
	=	1.33

Senseonics Holdings (AMEX:SENS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Senseonics Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Senseonics Holdings (Senseonics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

6L6:Germany 6L6:Germany

Address

20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005

Website

https://www.senseonics.com

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Executives

Sharon Larkin	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder	director	160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain	officer: VP Operations, Qual & Reg	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino	director	1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio	officer: VP Global Sales & Marketing	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow	director, officer: President & Chief Exec Officer	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman	officer: Chief Medical Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton	officer: GC & Corp. Development Advisor	VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco	director	ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince	director	20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876